Skip to main content

Animations

MJFF Publications

7231 - 7240 of 7939 Results
Title
Year
  • Year
  • 2013
  • 2013
  • 2013
  • 2013
  • 2013
  • 2013
  • 2013
  • 2013
  • 2013
  • 2013
  • OPEN
    Title: Dopamine and its metabolites in cathepsin D heterozygous mice before and after MPTP administration
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2013.01.035
    Citation Count: 10
  • OPEN
    Title: Diabetes is associated with postural instability and gait difficulty in Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.01.016
    Citation Count: 101
  • OPEN
    Title: Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin®) injections in blepharospasm
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00702-013-0998-9
    Citation Count: 58
  • OPEN
    Title: Human α4β2 Nicotinic Acetylcholine Receptor as a Novel Target of Oligomeric α-Synuclein
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0055886
    Citation Count: 13
  • RESTRICTED
    Title: No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p04.187
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p06.049
    Best OA location URL:
    Citation Count: 2
  • OPEN
    Title: The temporal pattern of stimulation may be important to the mechanism of deep brain stimulation
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2013.02.001
    Citation Count: 81
  • OPEN
    Title: Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0055031
    Citation Count: 106
  • RESTRICTED
    Title: Which dyskinesia scale best detects treatment response?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25321
    Best OA location URL:
    Citation Count: 80
  • OPEN
    Title: The natural history of multiple system atrophy: a prospective European cohort study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/s1474-4422(12)70327-7
    Citation Count: 459
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.